![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/17 | |
A61P 35/00 |
(11) | Number of the document | 2205257 |
(13) | Kind of document | T |
(96) | European patent application number | 08836333.8 |
Date of filing the European patent application | 2008-10-03 | |
(97) | Date of publication of the European application | 2010-07-14 |
(45) | Date of publication and mention of the grant of the patent | 2013-09-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2008/002653 |
Date | 2008-10-03 |
(87) | Number | WO 2009/044273 |
Date | 2009-04-09 |
(30) | Number | Date | Country code |
07291214 | 2007-10-05 | EP |
(72) |
TRIEBEL, Frédéric, FR
|
(73) |
Immutep,
Parc Club Orsay 2, Rue Jean Rostand, 91400 Orsay,
FR
|
(54) | LAG-3Ig (IMP321) dosage regimes for use in the treatment of cancer |
LAG-3Ig (IMP321) dosage regimes for use in the treatment of cancer |